लोड हो रहा है...
Rofecoxib and Clinically Significant Upper and Lower GI Events Revisited based on documents from recent litigation.
BACKGROUND: Based on published data, it is widely believed and cited that rofecoxib use is associated with approximately a 50% reduction in significant gastrointestinal complications such as bleeding. METHODS: Data made available as part of litigation, including the VIGOR trial and an Azlheimers’ st...
में बचाया:
| मुख्य लेखकों: | , , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2011
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3203315/ https://ncbi.nlm.nih.gov/pubmed/21986300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MAJ.0b013e3182113658 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|